Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?
- 1 August 1999
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 45 (1) , 41-45
- https://doi.org/10.1016/s0360-3016(99)00138-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialRadiotherapy and Oncology, 1997
- A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancerRadiotherapy and Oncology, 1997
- Feasibility and outcome of a progressively accelerated concomitant boost radiotherapy schedule for head and neck carcinomasInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Early and Long-term Results of an Original Accelerated Radiation Therapy Schedule in Head and Neck CarcinomaActa Oncologica, 1997
- Idealized versus realized overall treatment timesInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- Loss of local control with prolongation in radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factorsRadiotherapy and Oncology, 1989
- The hazard of accelerated tumor clonogen repopulation during radiotherapyActa Oncologica, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958